发明名称 |
Priming solutions for cardiopulmonary bypass |
摘要 |
The present invention relates to priming solutions used during cardiopulmonary bypass procedures. In particular, the present invention relates to a cardiopulmonary bypass priming solution comprising a balanced salt solution and a combination of oncotic and non-oncotic dextran molecules. The present invention also relates to the use of the priming solution in a cardiopulmonary bypass method, a method of maintaining oncotic pressure in a patient during a cardiopulmonary bypass procedure, and a combination of cardiopulmonary bypass priming solution and cardiopulmonary bypass apparatus. |
申请公布号 |
US8969323(B2) |
申请公布日期 |
2015.03.03 |
申请号 |
US201113634934 |
申请日期 |
2011.11.07 |
申请人 |
XVIVO Perfusion AB |
发明人 |
Steen Stig |
分类号 |
A61K31/721;A61K31/191;A61K33/14;A61K9/00;A61K9/06 |
主分类号 |
A61K31/721 |
代理机构 |
Pearne & Gordon LLP |
代理人 |
Pearne & Gordon LLP |
主权项 |
1. A method of maintaining oncotic pressure in a patient during a cardiopulmonary bypass procedure, comprising contacting the patient, during the cardiopulmonary bypass procedure, with a cardiopulmonary bypass priming solution comprising a balanced salt solution and a combination of an oncotic dextran and a non-oncotic dextran, wherein the oncotic dextran provides a functional oncotic pressure corresponding to 35 to 55 g/l of Dextran 40. |
地址 |
Göteborg SE |